Investigating emerging infectious diseases and developing medical countermeasures
Official title: Integrated Services Core
Funded at University of Pittsburgh at Pittsburgh · NIH-10910185 · Data updated 2026-11-12
This study is all about figuring out how infectious diseases start and spread, especially during pandemics, so that researchers can create better vaccines and treatments to help keep you and your loved ones safe from these illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $879,285 |
| NIH project number | 5UC7AI180311-02 |
| Project ID | NIH-10910185 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those involved in public health and infectious disease management.
✕Less likely to help
Patients with established chronic infections that are not related to emerging pathogens may not receive direct benefits from this research.
What this research studies
This research focuses on understanding how infectious diseases emerge and spread, particularly in the context of pandemics. The team at the Regional Biocontainment Laboratory collaborates across various disciplines to study the biology of pathogens and their interactions with hosts. By utilizing advanced biosafety level-3 facilities, they aim to accelerate the development of new vaccines and treatments that can be deployed in response to biological threats. Patients may benefit from this research through the eventual availability of effective medical interventions for infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and treatments that protect against emerging infectious diseases.
How similar studies have gone: Previous research in similar biocontainment settings has shown success in developing vaccines and treatments for infectious diseases, indicating a promising potential for this approach.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Duprex, William Paul — University of Pittsburgh at Pittsburgh
- Study coordinator: Duprex, William Paul
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.